Clinical Trial Update: Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding topical fluticasone propionate 0.05% cream to NB-UVB phototherapy improves outcomes in active non-segmental vitiligo com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-segmental Vitiligo

Drugs mentioned

• Fluticasone propionate 0.05% cream (fluticasone propionate)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Patients With Active Non-segmental Vitiligo., Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05% | Phase 4 | Status: UNKNOWN